Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Giulio Emilio Brancati, Donatella Acierno, Margherita Barbuti, Camilla Elefante, Samuele Gemignani, Accursio Raia & Giulio Perugi. (2023) Revisiting stimulant use for emotional dysregulation in attention-deficit/hyperactivity disorder (ADHD). Expert Review of Neurotherapeutics 23:11, pages 981-994.
Read now
Read now
Doris Susanne Konrad-Bindl, Ursula Gresser & Barbara Maria Richartz. (2016) Changes in behavior as side effects in methylphenidate treatment: review of the literature. Neuropsychiatric Disease and Treatment 12, pages 2635-2647.
Read now
Read now
Edmund JS Sonuga-Barke, Johanna Koerting, Elizabeth Smith, Donna C McCann & Margaret Thompson. (2011) Early detection and intervention for attention-deficit/hyperactivity disorder. Expert Review of Neurotherapeutics 11:4, pages 557-563.
Read now
Read now
Articles from other publishers (12)
Kristine Kaalund-Brok, Tine Bodil Houmann, Marie Bang Hebsgaard, Maj-Britt Glenn Lauritsen, Louise Hyldborg Lundstrøm, Helene Grønning, Lise Darling, Susanna Reinert-Petersen, Morten Aagaard Petersen, Jens Richardt Møllegaard Jepsen, Anne Katrine Pagsberg, Kerstin Jessica Plessen, Henrik Berg Rasmussen & Pia Jeppesen. (2021) Outcomes of a 12-week ecologically valid observational study of first treatment with methylphenidate in a representative clinical sample of drug naïve children with ADHD. PLOS ONE 16:10, pages e0253727.
Crossref
Crossref
Tanya E. FroehlichWilliam B. BrinkmanJames L. PeughAlexandra N. PiedraDaniel J. VitucciJeffery N. Epstein. (2020) Pre-Existing Comorbid Emotional Symptoms Moderate Short-Term Methylphenidate Adverse Effects in a Randomized Trial of Children with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology 30:3, pages 137-147.
Crossref
Crossref
Ole Jakob Storebø, Nadia Pedersen, Erica Ramstad, Maja Laerke Kielsholm, Signe Sofie Nielsen, Helle B Krogh, Carlos R Moreira-Maia, Frederik L Magnusson, Mathilde Holmskov, Trine Gerner, Maria Skoog, Susanne Rosendal, Camilla Groth, Donna Gillies, Kirsten Buch Rasmussen, Dorothy Gauci, Morris Zwi, Richard Kirubakaran, Sasja J Håkonsen, Lise Aagaard, Erik Simonsen & Christian Gluud. (2018) Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Maria G. Valdovinos. 2016. Behavioral Health Promotion and Intervention in Intellectual and Developmental Disabilities. Behavioral Health Promotion and Intervention in Intellectual and Developmental Disabilities
1
19
.
Donna C McCann, Margaret Thompson, David Daley, Joanne Barton, Cathy Laver-Bradbury, Judy Hutchings, David Coghill, Louise Stanton, Tom Maishman, Liz Dixon, Josh Caddy, Maria Chorozoglou, James Raftery & Edmund Sonuga-Barke. (2014) Study protocol for a randomized controlled trial comparing the efficacy of a specialist and a generic parenting programme for the treatment of preschool ADHD. Trials 15:1.
Crossref
Crossref
Jungeun Song, Hyun Ju Hong, Byung Ook Lee & Ki-Hwan Yook. (2014) Association of Norepinephrine Transporter Gene and Side Effects of Osmotic-Release Oral System Methylphenidate in Attention-Deficit Hyperactivity Disorder. Journal of the Korean Academy of Child and Adolescent Psychiatry 25:2, pages 82-88.
Crossref
Crossref
Bjørn E. RamtvedtHenning S. AabechKjetil Sundet. (2014) Minimizing Adverse Events While Maintaining Clinical Improvement in a Pediatric Attention-Deficit/Hyperactivity Disorder Crossover Trial with Dextroamphetamine and Methylphenidate. Journal of Child and Adolescent Psychopharmacology 24:3, pages 130-139.
Crossref
Crossref
Caroline Davis, Liana Fattore, Allan S. Kaplan, Jacqueline C. Carter, Robert D. Levitan & James L. Kennedy. (2011) The suppression of appetite and food consumption by methylphenidate: the moderating effects of gender and weight status in healthy adults. The International Journal of Neuropsychopharmacology 15:02, pages 181-187.
Crossref
Crossref
Jin-Sun Kim, Bung-Nyun Kim, Soo-Churl Cho, Min-Sup Shin, Hee-Jeong Yoo, Jae-Won Kim, Dong-Ho Song, Dong-Won Shin, Yoo-Sook Joung, Keun-Ah Cheon, Yee-Jin Shin, Ye-Ni Kim & Eun-Hye Ha. (2010) The Side Effects and Correlates of OROS-Methylphenidate in the Treatment of Children and Adolescents with ADHD. Journal of korean Academy of Child and Adolescent Psychiatry 21:2, pages 63-71.
Crossref
Crossref
Edmund J.S. Sonuga‐Barke & Jeffrey M. Halperin. (2010) Developmental phenotypes and causal pathways in attention deficit/hyperactivity disorder: potential targets for early intervention?. Journal of Child Psychology and Psychiatry 51:4, pages 368-389.
Crossref
Crossref
Edmund J.S. Sonuga-BarkeDavid CoghillTimothy WigalMarc DeBackerJames Swanson. (2009) Adverse Reactions to Methylphenidate Treatment for Attention-Deficit/Hyperactivity Disorder: Structure and Associations with Clinical Characteristics and Symptom Control. Journal of Child and Adolescent Psychopharmacology 19:6, pages 683-690.
Crossref
Crossref
. (2008) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 17:9.
Crossref
Crossref